Cite
Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies.
MLA
Ortega, Miguel A., et al. “Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies.” Current Oncology, vol. 29, no. 4, Apr. 2022, pp. 2442–53. EBSCOhost, https://doi.org/10.3390/curroncol29040198.
APA
Ortega, M. A., Pekarek, L., Fraile-Martinez, O., Garcia-Montero, C., Saez, M. A., Asúnsolo, A., Alvarez-Mon, M. A., Monserrat, J., Ruiz-Llorente, L., García-Honduvilla, N., Albillos, A., Buján, J., Alvarez-Mon, M., & Guijarro, L. G. (2022). Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies. Current Oncology, 29(4), 2442–2453. https://doi.org/10.3390/curroncol29040198
Chicago
Ortega, Miguel A., Leonel Pekarek, Oscar Fraile-Martinez, Cielo Garcia-Montero, Miguel A. Saez, Angel Asúnsolo, Miguel A. Alvarez-Mon, et al. 2022. “Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies.” Current Oncology 29 (4): 2442–53. doi:10.3390/curroncol29040198.